Press Releases

Headlands Research Enters the Caribbean with Acquisition of CMRCenter

The deal pairs San Juan, Puerto Rico site’s deep community ties, top-tier enrollment, and 90% retention with Headlands’ network-wide infrastructure and resources to accelerate clinical research

PHARMASEAL and Viedoc Announce a Technical Integration Partnership

PHARMASEAL, provider of the Engility® Trial Management Platform consisting of a Clinical Trial Management System (CTMS) CTMS and Electronic Trial Master File (eTMF), has announced a Technology Integration Partnership with Viedoc, a global leader in Electronic Data Capture (EDC) and eClinical technologies. This collaboration integrates PHARMASEAL’s advanced CTMS platform with Viedoc’s cutting-edge EDC capabilities, including its flagship product Viedoc Clinic, to deliver a more integrated solution for life science companies managing clinical trials worldwide.

Gene by Gene Supports Landmark Pharmacogenomics Trial to Personalize Prescribing in NHS Scotland

Gene by Gene Supports Landmark Pharmacogenomics Trial to Personalize Prescribing in NHS Scotland

Takara Bio Europe signs distribution agreement with MACHEREY-NAGEL to expand access to high-quality bioanalysis products

Takara Bio Europe is pleased to announce it has entered into a distribution agreement with MACHEREY-NAGEL to expand access to high-quality bioanalysis products.

Alithea Genomics Announces the Launch of MERCURIUS™ FLASH-seq: A Plate-Based, Full-Length Single Cell RNA-seq Kit Delivering Exceptional Sensitivity and Simplicity

Alithea Genomics has announced the commercial launch of MERCURIUS™ FLASH-seq, a next-generation library preparation kit for full-length single-cell RNA sequencing.

Phastar appoints Industry Veteran Billy Amzal as Head of Strategic Consulting

Phastar, a global specialist biometrics & data science Contract Research Organization (CRO), today announced the appointment of Billy Amzal as Head of Strategic Consulting.

New Collaboration Initiative: Alfa Chemistry Announces Inclusion as a Listed Supplier across CHEMnetBASE Dictionaries

To make it easier for researchers to find and access the specialized chemicals they need, Alfa Chemistry has announced that it has been added as a supplier to the CHEMnetBASE dictionaries, the world’s premier collection of interactive chemistry databases from CRC Press, Taylor & Francis Group. This means that Alfa Chemistry’s vast catalog of specialized chemicals will be easily discoverable within the premier digital chemistry resource used by researchers and scientists around the world.

Association for Molecular Pathology Publishes Best Practice Recommendations for Clinical HRD Testing

AMP recently published a new report with 12 best practice recommendations focused on the design and validation of clinical HRD assays. To develop these recommendations, AMP assembled an expert panel that included organizational representation from ACCC, ASCO, and the CAP.

Alithea Genomics Launches MERCURIUS™ Total DRUG-seq: A Next-Generation Full-Length Transcriptome Profiling Platform for High-Throughput Compound Screening and Target Validation

Alithea Genomics has announced the launch of MERCURIUS™ Total DRUG-seq to push the boundaries of high-throughput drug screens, toxicology screens and target validation.

Lindus Health Named Fierce CRO Award Winner in the Outstanding Patient Recruitment and Retention Category

Lindus Health Named Fierce CRO Award Winner in the Outstanding Patient Recruitment and Retention Category

Symbiosis Expands Global Reach with Key Appointment of Angelika Rublack as Senior Business Development Manager

One2Treat, the leading company incorporating the patient voice into clinical development, launches One2Treat Voice app

One2Treat SA, a fast-growing tech company incorporating the patient voice in all strategic decisions about treatment assessments in Pharma R&D, today announced the launch of the One2Treat Voice app, a new module of their software platform.

START Launches Hope Hub to Connect Patients, Physicians, and Advocacy Groups to Community-Based Cancer Trials

The new platform is designed to break down barriers to early-phase trial access, bringing "Hope Through Access" to communities and patients who need it most.

Advarra establishes AI council in partnership with life sciences leaders to drive collaboration and advance innovation in clinical trials

Sanofi, Recursion, and Velocity Clinical Research executives join AI council as founding members to guide responsible AI use in clinical research and drive tangible improvements in study design and operational outcomes

BeWell Family Care and Axsendo Clinical Research Announce Strategic Clinical Research Partnership in Phoenix, Arizona

About BeWell Family Care BeWell Family Care is a community-based primary care practice committed to delivering comprehensive and compassionate medical care across the lifespan. With a patient-first approach and strong community ties, BeWell is redefining access to quality care in Arizona. About Axsendo Clinical Research Axsendo Clinical Research is an independent research organization providing full-service support for Phase I-IV clinical trials. With a growing network of investigators and a commitment to operational excellence, Axsendo delivers high-quality research outcomes across a wide range of therapeutic areas.

Astoriom Appoints Brittany Jackson as CFO

Key appointment to lead the company’s financial strategy and support continued global growth in sample stability and biorepository storage solutions

ClearNote Health Avantect® Pancreatic Cancer Test Enters Patient Enrollment Phase of Groundbreaking UK Study Targeting High-Risk Patients

ClearNote Health announced initiation of patient enrollment for a new study that aims to advance early detection of pancreatic cancer in individuals newly diagnosed with type 2 diabetes.

Duke Street Bio receives FDA Fast Track designation for PARP1-selective inhibitor DSB2455 in patients with HRD brain metastases from triple-negative breast cancer

Duke Street Bio has announced that the FDA has granted Fast Track designation to DSB2455, its next-generation, CNS-active selective PARP1 inhibitor.

WCG CenterWatch Celebrates Excellence in Clinical Trial Collaborations with Inaugural Pinnacle Award for Site Relationships

WCG proudly announces the winners of the first-ever prestigious WCG Pinnacle Award, Site Relationships. Award winners were chosen based on the results of WCG’s 2025 CenterWatch Global Site Relationship Survey that captured insights from more than 12,000 respondents.

MIB Agents' Community of Families Has Awarded $2.5M in Grants to Research Pediatric Bone Cancer

MIB Agents, a leading pediatric osteosarcoma nonprofit, announced it has awarded $2.5 million in research grants through its OutSmarting Osteosarcoma program, which is powered by families honoring children affected by the disease. At its upcoming FACTOR Conference (June 26–28) in Salt Lake City, the organization will award $700,000 in grants to 10 scientists advancing less toxic, more effective treatments. The grants, which include four $100,000 Hero Grants and six $50,000 Hope Young Investigator Grants, reflect a unique collaboration between researchers and the osteosarcoma community, with families actively funding and participating in the review of scientific proposals.